BioRender 图标

Adult 5 (gender-neutral, stage I obesity, anterior)

Adult 5 (gender-neutral, stage I obesity, anterior) - Editable icon of an obese gender-neutral adult standing in anterior view
[{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb42149f/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb42149f/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214a0/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214a0/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214a1/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214a1/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214a2/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214a2/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214a3/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214a3/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214a4/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214a4/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214a5/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214a5/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214a6/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214a6/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214a7/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214a7/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214a8/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214a8/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214a9/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214a9/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214aa/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214aa/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214ab/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214ab/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214ac/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214ac/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214ad/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214ad/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214ae/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214ae/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214af/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214af/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214b0/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214b0/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214b1/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214b1/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214b2/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214b2/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214b3/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214b3/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214b4/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214b4/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214b5/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214b5/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214b6/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214b6/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214b7/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214b7/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214b8/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214b8/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214b9/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214b9/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214ba/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214ba/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214bb/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214bb/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214bc/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214bc/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214bd/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214bd/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214be/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214be/66d8bc1f93a5b4e1eb421472.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d8bc6693a5b4e1eb4214bf/66d8bc1f93a5b4e1eb421472.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d8bc6693a5b4e1eb4214bf/66d8bc1f93a5b4e1eb421472.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍
page dashboard

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
head,shoulders,bust,gender neutral,gender neutral adult,overweight,obesity,obese,obesity stage I,high BMI,excess weight,large,chubby,plus-sized,heavy,full-figured,above average weight,stage 1 obesity,stage one,adult 5,adult five,Hispanic,Spanish,Cuban,Mexican,Puerto Rican,South American,Central American Latin American,pathology,diseased,disease,sick,sickly,pathological,abnormal,ill,unwell,unhealthy,adult,mature,grown,full-grown,young adult,middle adult,old adult,intersex,unisex,person,asexual,unsexed sexless,gender-neutral,standing,upright,vertical,standing upright,stand,human,human figure,adult,anterior,frontal,front view,anterior view,front,body,upper body,torso,limbs,arm,leg,hand,foot,feet,full body,people,figure,head,woman,man,male,female,anterior,front,anatomical position,eyes open,research,scientific research,scientific study,laboratory research,animal research,anatomy,pathology,immunology,behavior,medicine,physiology,genetics,biology,psychology,feeder,24q2-content-refinement,24q2-content-refinement-human-figure-diversity,obese,hispanic,fat
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Adult 5 (gender-neutral, stage I obesity, anterior) icon JPEG

Adult 5 (gender-neutral, stage I obesity, anterior) icon PNG

Adult 5 (gender-neutral, stage I obesity, anterior) icon SVG

Adult 5 (gender-neutral, stage I obesity, anterior) icon GIF

BioRender 图标常见问题解答

How are scientists using the Adult 5 (gender-neutral, stage I obesity, anterior) icon in their work?

BioRender users often use the Adult 5 (gender-neutral, stage I obesity, anterior) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Human Anatomy.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Adult 5 (gender-neutral, stage I obesity, anterior) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Adult 5 (gender-neutral, stage I obesity, anterior) icon customizable in BioRender?

Most icons in BioRender, including the Adult 5 (gender-neutral, stage I obesity, anterior) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Adult 5 (gender-neutral, stage I obesity, anterior) icon for publication or presentations?

Yes, figures containing the Adult 5 (gender-neutral, stage I obesity, anterior) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Adult 5 (gender-neutral, stage I obesity, anterior) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Adult 5 (gender-neutral, stage I obesity, anterior) icon — especially those focused on Human Anatomy. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Adult 5 (gender-neutral, stage I obesity, anterior) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon